0.514
0.0241 (4.92%)
0.0241 (4.92%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aeterna Zentaris Inc | AEZS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.0241 | 4.92% | 0.514 | 00:00:01 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 0.514 | 0.4791 | 0.5199 | 0.485 | 0.4899 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.46 | 0.63 | 0.17 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,955 | 4,309,219 | $ 0.5052454 | $ 2,177,213 | 6,997,545 | 0.36 - 2.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:52 | formt | 5,500 | $ 0.514 | USD |
Aeterna Zentaris Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 21.14M | 41.13M | 16.44M | $ 532.00k | $ - | 0.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Aeterna Zentaris News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AEZS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.449 | 0.585 | 0.4455 | 0.5220129 | 8,745,142 | 0.065 | 14.48% |
| 1 Month | 0.475 | 0.585 | 0.415 | 0.4866218 | 5,557,239 | 0.039 | 8.21% |
| 3 Months | 1.08 | 1.29 | 0.36 | 0.483052 | 4,128,186 | -0.566 | -52.41% |
| 6 Months | 1.16 | 1.38 | 0.36 | 0.52332 | 2,117,494 | -0.646 | -55.69% |
| 1 Year | 2.29 | 2.57 | 0.36 | 0.5702314 | 1,131,468 | -1.78 | -77.55% |
| 3 Years | 2.05 | 5.5869 | 0.36 | 1.32 | 611,524 | -1.54 | -74.93% |
| 5 Years | 15.00 | 15.95 | 0.36 | 6.01 | 2,102,539 | -14.49 | -96.57% |
Aeterna Zentaris Description
| AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company is actively pursuing opportunities to commercialize macimorelin in the EU & the rest of the world. |
